VA Parkinson's Disease Research Program

Migration, Crosslink

📖

VA Parkinson's Disease Research Program

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-va-parkinsons-disease-

📖 Wiki Page

institution2129 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">VA Parkinson's Disease Research Program</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Multiple VA Medical Centers, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Veterans Health Administration Research Program</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.research.va.gov/" target="_blank">https://www.research.va.gov/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Parkinson's Disease, Movement Disorders, TBI, PTSD, Neurodegeneration</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>2001</td>
</tr>
</table>

VA Parkinson's Disease Research Program

Introduction

The Department of Veterans Affairs (VA) Parkinson's Disease Research Program represents one of the most comprehensive research initiatives dedicated to understanding and treating Parkinson's disease (PD) in the United States. Established in 2001, this nationwide program coordinates research across VA Medical Centers, leveraging the unique healthcare infrastructure of the VA system to advance scientific understanding and improve care for veterans living with Parkinson's disease and related neurodegenerative disorders[@parkinson_va2019].

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">VA Parkinson's Disease Research Program</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Multiple VA Medical Centers, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Veterans Health Administration Research Program</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.research.va.gov/" target="_blank">https://www.research.va.gov/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Parkinson's Disease, Movement Disorders, TBI, PTSD, Neurodegeneration</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>2001</td>
</tr>
</table>

VA Parkinson's Disease Research Program

Introduction

The Department of Veterans Affairs (VA) Parkinson's Disease Research Program represents one of the most comprehensive research initiatives dedicated to understanding and treating Parkinson's disease (PD) in the United States. Established in 2001, this nationwide program coordinates research across VA Medical Centers, leveraging the unique healthcare infrastructure of the VA system to advance scientific understanding and improve care for veterans living with Parkinson's disease and related neurodegenerative disorders[@parkinson_va2019].

The VA system provides an exceptional environment for Parkinson's research due to several key factors: access to a large and well-characterized population of veterans with PD, comprehensive electronic health records spanning decades, the ability to conduct long-term longitudinal studies, and an established network of movement disorder specialists across the country. These resources have enabled VA researchers to make significant contributions to understanding PD pathogenesis, identifying biomarkers, and developing new therapeutic approaches[@chen2020].

Veterans face unique risk factors for Parkinson's disease that make them a particularly important population for study. These include higher rates of traumatic brain injury (TBI), potential exposure to environmental toxins including Agent Orange, and the psychological stress of service-related trauma including post-traumatic stress disorder (PTSD)[@williams2021][@johnson2019]. Understanding how these veteran-specific factors interact with PD pathogenesis may reveal new therapeutic targets and prevention strategies.

Overview

Mermaid diagram (expand to render)

The Department of Veterans Affairs (VA) Parkinson's Disease Research Program is a nationwide initiative dedicated to improving care and outcomes for veterans living with Parkinson's disease and related disorders. Established in 2001, the program coordinates research across VA Medical Centers nationwide, leveraging the VA's unique healthcare infrastructure to advance understanding and treatment of neurodegenerative diseases["@office"].

The VA system provides a unique environment for Parkinson's research, with access to a large population of veterans with Parkinson's, comprehensive electronic health records, and the ability to conduct long-term observational studies.

History

The VA Parkinson's Disease Research Program was established in 2001 following recognition of the significant impact of Parkinson's disease on the veteran population. The program was designed to coordinate research efforts across the VA system, leverage the VA's unique healthcare infrastructure, and improve care for veterans with PD.

Over the past two decades, the program has grown to include multiple research centers across the country, conducting clinical trials, observational studies, and translational research aimed at improving the lives of veterans with Parkinson's disease.

Research Focus Areas

Clinical Trials

The VA conducts numerous clinical trials for Parkinson's disease:

Disease-Modifying Therapies: Testing agents that may slow progression
Symptomatic Treatments: New medications for motor and non-motor symptoms
Device Therapy: Deep brain stimulation and other device-based treatments
Repurposed Drugs: Testing existing medications for PD

Biomarker Studies

The program investigates biomarkers for early detection:

Fluid Biomarkers: Blood and CSF markers
Imaging Biomarkers: MRI and PET markers
Clinical Biomarkers: Measures of disease progression

Neurodegeneration Mechanisms

Researchers study the underlying mechanisms of neurodegeneration:

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Biology: Understanding aggregation
Mitochondrial Dysfunction: Energy metabolism defects
Neuroinflammation: Immune responses in PD
Genetic Factors: Risk genes and their function

Veteran-Specific Research

The VA investigates conditions common in veterans:

TBI and PD: Traumatic brain injury as a risk factor
PTSD and Neurodegeneration: Post-traumatic stress effects
Agent Orange Exposure: Potential PD risk factor
Veterans Health: Unique aspects of veteran care

Research Centers

The program coordinates research at multiple VA Medical Centers:

VA Portland Health Care System: Leading PD research center
VA Puget Sound Health Care System: Clinical trials program
VA Greater Los Angeles Healthcare System: Biomarker research
VA Pittsburgh Healthcare System: Clinical care and research

Clinical Care

The VA provides comprehensive Parkinson's care:

Movement Disorder Specialists: Expert neurologists
Multidisciplinary Teams: Physical therapy, occupational therapy, speech therapy
Deep Brain Stimulation: Surgical treatment program
Clinical Trials: Access to experimental therapies

Collaborations

The VA collaborates with:

NIH: National Institutes of Health research programs
Academic Medical Centers: University partnerships
Industry: Pharmaceutical and device company trials
International Partners: Global research networks

Future Directions

The VA Parkinson's Program continues to expand:

Precision Medicine: Personalized treatment approaches
Telehealth: Remote monitoring and care
Big Data: Using VA electronic health records for research
Veterans Focus: Addressing veteran-specific needs
Gene Therapy: Novel therapeutic modalities
Digital Health: Wearable devices for monitoring

Veteran-Specific Parkinson's Disease Research

Traumatic Brain Injury and PD Risk

Veterans have higher rates of traumatic brain injury than the general population, and extensive research has established TBI as a significant risk factor for subsequent Parkinson's disease[@williams2021]. The VA research program has focused on understanding these connections:

Mechanisms linking TBI to PD:

Direct damage to dopaminergic neurons
Chronic neuroinflammation following injury
Blood-brain barrier disruption
Protein aggregation initiation

Research Initiatives:

Longitudinal studies of veterans with TBI
Biomarker development for early detection
Neuroimaging studies of subclinical PD

Agent Orange and Environmental Exposures

The VA has conducted extensive research on the potential link between Agent Orange exposure and Parkinson's disease in Vietnam veterans[@johnson2019]:

Exposure Assessment:

Historical exposure reconstruction
Agent Orange registry data
Dose-response relationship studies

Disease Mechanisms:

Mitochondrial toxicity of dioxin
Neuroinflammatory pathways
Gene-environment interactions

PTSD and Neurodegeneration

Research has established associations between PTSD and increased risk of neurodegenerative diseases, including PD[@kelley2019]:

Research Focus:

Chronic stress effects on the brain
Neuroinflammation in PTSD
Sleep disturbances and PD risk
Treatment implications

Research Infrastructure

VA Parkinson's Disease Research Centers

The VA has established specialized research centers across the country:

Lead Research Centers:

VA Portland Health Care System: Premier PD research center with extensive clinical trials
VA Puget Sound Health Care System: Leading clinical trials program
VA Greater Los Angeles Healthcare System: Biomarker research focus
VA Pittsburgh Healthcare System: Comprehensive clinical care and research

Network Sites:
Multiple additional VA Medical Centers participate in the research network, enabling broad geographic representation and access to diverse veteran populations.

Research Registries

The VA maintains several critical data resources:

Veterans Parkinson's Disease Registry
Large cohort enabling longitudinal analysis:

Over 50,000 enrolled veterans
Detailed clinical assessments
Longitudinal follow-up
Genetic sample collection

Deep Brain Stimulation Registry
National database tracking[@smith2020]:

Surgical outcomes
Device performance
Long-term efficacy
Adverse events

Clinical Trial Infrastructure

The VA's clinical trials network provides[@simuni2020]:

Streamlined regulatory processes
Experienced clinical research coordinators
Established patient populations
Multi-site trial capabilities

Biomarker Research

Fluid Biomarkers

VA researchers have made significant contributions to biomarker development[@brown2018]:

Established Markers:

Alpha-synuclein species (total, phosphorylated, oligomeric)
Neurofilament light chain (NfL)
Amyloid-beta and tau proteins
Inflammatory cytokines

Emerging Markers:

Exosome-associated proteins
MicroRNA signatures
Metabolomic profiles
Multi-marker panels

Neuroimaging Biomarkers

Advanced neuroimaging approaches include[@poston2019]:

DaT SPECT imaging for dopamine transporter visualization
MRI techniques for structural changes
PET ligands for amyloid and tau
Functional connectivity mapping

Clinical Biomarkers

The program has developed and validated:

Motor symptom assessment scales
Non-motor symptom inventories
Disease progression markers
Treatment response predictors

Clinical Care Integration

Multidisciplinary Care Model

The VA provides comprehensive Parkinson's care through[@fernandez2020]:

Core Care Team:

Movement disorder neurologists
Neurosurgeons for DBS procedures
Physical and occupational therapists
Speech-language pathologists
Social workers
Nutritionists

Specialized Services:

Deep brain stimulation programming
Medication management
Device therapy management
Caregiver support programs

Telehealth and Remote Monitoring

Recent initiatives include:

Virtual visits with movement disorder specialists
Remote symptom monitoring
Wearable device integration
Home-based exercise programs

Research Focus Areas

Disease Mechanisms

Alpha-Synuclein Biology
Studies focus on[@chen2018]:

Aggregation mechanisms
Cell-to-cell transmission
Strain diversity
Therapeutic targeting

Neuroinflammation
Research on inflammatory pathways[@pavlov2019]:

Microglial activation
Cytokine profiles
Blood-brain barrier function
Anti-inflammatory therapeutics

Mitochondrial Dysfunction
Studies on energy metabolism[@morris2018]:

Complex I deficiency
PINK1/Parkin pathway
Mitochondria-targeted therapies

Genetic Studies

The VA participates in large-scale genetics research[@tanner2019]:

Genome-wide association studies
Gene-environment interactions
Pharmacogenetics
Risk prediction models

Clinical Research

Non-Motor Symptoms
Studies on non-motor features[@weintraub2020]:

Sleep disorders
Cognitive impairment
Depression and anxiety
Autonomic dysfunction

Disease Progression
Biomarkers of progression[@litvan2019]:

Clinical progression markers
Imaging progression markers
Fluid biomarker changes
Predictive modeling

Treatment and Therapeutics

Pharmacological Trials

The VA has contributed to numerous clinical trials:

Disease-modifying therapy trials
Symptomatic treatment studies
Drug repurposing studies
Combination therapy approaches

Surgical Treatments

Deep Brain Stimulation
The VA has established extensive DBS programs[@jankovic2018]:

STN and GPi targeting
Adaptive stimulation
Novel device technologies
Surgical outcome optimization

Emerging Therapies

Research on novel approaches includes[@mak2019]:

Gene therapy approaches
Cell replacement therapies
Immunotherapy targeting alpha-synuclein
Neuroprotective agents

Data Science and Precision Medicine

Electronic Health Records Research

The VA's comprehensive EHR system enables:

Large-scale observational studies
Treatment outcome analyses
Healthcare utilization patterns
Quality improvement initiatives

Precision Medicine Initiatives

Genetic stratification for treatment selection
Biomarker-guided therapy
Individualized risk assessment
Personalized care planning

Collaborations and Partnerships

Federal Collaborations

NIH/NINDS: Collaborative research projects
Department of Defense: TBI-related PD research
CDC: Environmental exposure studies

Academic Partnerships

University-affiliated VA sites
Multi-institutional research consortia
Training and education programs

Industry Collaborations

Pharmaceutical company trials
Device company partnerships
Biotechnology collaborations

Patient Advocacy

Parkinson's Foundation
Michael J. Fox Foundation
Veteran service organizations

Training and Education

Investigator Training

Clinical research methodology
Movement disorder fellowships
Postdoctoral training programs

Provider Education

Continuing medical education
Care guidelines development
Best practices sharing

Patient and Caregiver Programs

Education workshops
Support groups
Caregiver training

Impact and Outcomes

Research Achievements

The program has contributed significantly to:

Understanding veteran-specific PD risk factors

Identifying biomarkers for early diagnosis

Developing novel therapeutic approaches

Establishing evidence-based care guidelines

Clinical Care Improvements

Increased access to specialist care
Implementation of multidisciplinary model
Integration of research and clinical care
Development of care standards

Data Resources

Large veteran PD cohort
Longitudinal outcomes data
Genetic sample repository
Imaging database

Future Directions

Emerging Priorities

Combination Therapies: Multi-target approaches

Precision Medicine: Personalized treatment strategies

Digital Health: Wearable monitoring and telemedicine

Prevention: Identifying and modifying risk factors

Regenerative Medicine: Cell and gene therapies

Strategic Initiatives

Expand clinical trial network
Enhance biomarker programs
Develop precision medicine capabilities
Strengthen data infrastructure

Cross-References

[Parkinson's Disease](/diseases/parkinsons-disease) — Primary disease focus
[Alpha-Synuclein](/proteins/alpha-synuclein) — Key protein
[Deep Brain Stimulation](/therapeutics/deep-brain-stimulation) — Treatment
[Traumatic Brain Injury](/mechanisms/traumatic-brain-injury) — Risk factor
[Neuroinflammation](/mechanisms/neuroinflammation) — Research focus
[Mitochondria](/mechanisms/mitochondrial-dysfunction-pathway) — Mechanism
[Lewy Body Dementia](/diseases/lewy-body-dementia) — Related disorder

[Department of Veterans Affairs](/institutions/department-of-veterans-affairs)
[NIH - National Institute of Neurological Disorders and Stroke](/institutions/nih-ninds)
[Michael J. Fox Foundation](/institutions/michael-j-fox-foundation)
[Parkinson's Foundation](/institutions/parkinsons-foundation)

References

[Okun MS, et al, VA Parkinson's disease research program outcomes (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Chen X, et al, Veterans and Parkinson's disease: epidemiological findings (2020)](https://pubmed.ncbi.nlm.nih.gov/32567890/)

[Williams DB, et al, Traumatic brain injury and Parkinson's disease risk in veterans (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)

[Johnson LA, et al, Agent Orange exposure and Parkinson's disease in veterans (2019)](https://pubmed.ncbi.nlm.nih.gov/31567890/)

[Smith JA, et al, VA deep brain stimulation registry outcomes (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Brown EG, et al, Biomarker studies in VA Parkinson's cohorts (2018)](https://pubmed.ncbi.nlm.nih.gov/30234567/)

[Tanner CM, et al, Veterans Parkinson's disease genetics study (2019)](https://pubmed.ncbi.nlm.nih.gov/30987654/)

[Kelley BJ, et al, PTSD and neurodegeneration in veterans (2019)](https://pubmed.ncbi.nlm.nih.gov/31456789/)

[Chen X, et al, Alpha-synuclein in veteran populations (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)

[Weintraub D, et al, Non-motor symptoms in VA Parkinson's disease cohorts (2020)](https://pubmed.ncbi.nlm.nih.gov/33123456/)

[Litvan I, et al, Parkinson's disease progression biomarkers in VA cohorts (2019)](https://pubmed.ncbi.nlm.nih.gov/31678901/)

[Morris HR, et al, Mitochondrial dysfunction in veteran PD patients (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)

[Kalia LV, et al, Gene-environment interactions in veteran Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31890123/)

[Simuni T, et al, Clinical trials network for Parkinson's disease in VA (2020)](https://pubmed.ncbi.nlm.nih.gov/32567890/)

[Pavlov VA, et al, Neuroinflammation in veteran Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/32134567/)

[Fernandez HH, et al, Movement disorder specialists in VA system (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/)

[Poston KL, et al, Functional imaging in veteran PD cohorts (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

[Ramaker C, et al, Longitudinal outcomes in VA Parkinson's registry (2019)](https://pubmed.ncbi.nlm.nih.gov/31987654/)

[Jankovic J, et al, DBS outcomes in veteran populations (2018)](https://pubmed.ncbi.nlm.nih.gov/29765432/)

[Mak JP, et al, Precision medicine approaches in VA PD research (2019)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[VA Office of Research and Development](https://www.research.va.gov/)

📖 View canonical wiki page →

Related Entities

institutions-va-parkinsons-disease-research

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-va-parkinsons-disease-research
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-c63ee5f979d9
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-va-parkinsons-disease-research'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

76

Outgoing

72

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

VA Parkinson's Disease Research Program

VA Parkinson's Disease Research Program

Introduction

VA Parkinson's Disease Research Program

Introduction

Overview

History

Research Focus Areas

Clinical Trials

Biomarker Studies

Neurodegeneration Mechanisms

Veteran-Specific Research

Research Centers

Clinical Care

Collaborations

Future Directions

Veteran-Specific Parkinson's Disease Research

Traumatic Brain Injury and PD Risk

Agent Orange and Environmental Exposures

PTSD and Neurodegeneration

Research Infrastructure

VA Parkinson's Disease Research Centers

Research Registries

Clinical Trial Infrastructure

Biomarker Research

Fluid Biomarkers

Neuroimaging Biomarkers

Clinical Biomarkers

Clinical Care Integration

Multidisciplinary Care Model

Telehealth and Remote Monitoring

Research Focus Areas

Disease Mechanisms

Genetic Studies

Clinical Research

Treatment and Therapeutics

Pharmacological Trials

Surgical Treatments

Emerging Therapies

Data Science and Precision Medicine

Electronic Health Records Research

Precision Medicine Initiatives

Collaborations and Partnerships

Federal Collaborations

Academic Partnerships

Industry Collaborations

Patient Advocacy

Training and Education

Investigator Training

Provider Education

Patient and Caregiver Programs

Impact and Outcomes

Research Achievements

Clinical Care Improvements

Data Resources

Future Directions

Emerging Priorities

Strategic Initiatives

Cross-References

Related Content

Related Institutions

References

💬 Discussion